NEWS

Research firm Vital Transformation is preparing a new analysis about the impacts of the Inflation Reduction Act on biopharma investment,...

At We Work For Health (WWFH), our commitment to fostering health equity across the nation goes beyond advocacy—it extends to tangible,...

The biopharmaceutical industry is the backbone of America's innovative economy, supporting more than 4.9 million jobs across the United...

We Work For Health Executive Director Dan Leonard released the following statement in support of recently introduced legislation that...

As Congress returned to Washington, the Senate Judiciary Committee held a full committee hearing  to consider a number of critical bills...

Washington, DC  – New research contradicts promises of savings at the pharmacy counter for Medicare beneficiaries from the Inflation...

New research from the IQVIA Institute for Human Data Science further confirms what We Work For Health (WWFH) and others have warned...

The Drug Price Competition and Patent Term Restoration Act, more commonly known as the Hatch-Waxman Act, profoundly changed the...

Dear Chairman Sanders, Ranking Member Cassidy, and Members of the Committee:  The American medical innovation infrastructure that has...

As healthcare access and costs continue to dominate political conversations, the flaws in the Inflation Reduction Act are becoming...

In 1984, the Hatch-Waxman Act – formally known as the bipartisan Drug Price Competition and Patent Term Restoration Act  – established a...

During a recent We Work For Health roundtable with California Rep. Scott Peters, leaders across patient advocacy, biopharma, labor,...

While the 1980s is best remembered for its questionable fashion and cultural influence, two critical policies from early in the decade...

American innovation depends on a strong, robust intellectual property system that allows health care advances to save and enhance lives....

We Work For Health recently unveiled a new set of one-page resources designed to highlight the significant impact of the...

A version of this blog originally published as an op-ed in The Center Square in Arizona. We're sharing it here with additional updates...

Aug. 15, 2024 FOR IMMEDIATE RELEASE WASHINGTON, D.C. – We Work For Health Executive Director Dan Leonard issued the following statement...

The Biden administration this week is expected to claim victory on its stated goal of lowering drug prices for seniors. While the...

By Dan Leonard, WWFH Executive Director Intellectual property (IP) plays a crucial role in the success of the pharmaceutical and biotech...

On Monday, the Centers for Medicare and Medicaid Services (CMS) announced 2025 premiums for Medicare Part D plans will increase again....

Meena Seshamani, M.D., Ph.D. CMS Deputy Administrator and Director of the Center for Medicare Centers for Medicare & Medicaid Services...

During an event on Capitol Hill this week, California Rep. Scott Peters highlighted a graphic that clearly illustrates the distorted...

Despite the significant demand for effective non-opioid medications for the treatment of pain, a recent report from the Pioneer Institute...

SAN DIEGO – At a We Work For Health roundtable on June 20, the organization and its partners honored Rep. Scott Peters (CA-50) with the...

The National Institute of Standards and Technology (NIST) may soon finalize its controversial proposal to expand the scope of the...

For Immediate Release June 5, 2024 Contact: Lisa Glass 512-695-3569 / lglass@rosscomm.com New Data Reveals Strong Economic Impact of...

This week, the largest not-for-profit health insurance provider in Missouri, Blue KC, announced it will leave the Medicare Advantage...

The Centers for Medicare & Medicaid Services (CMS) recently released a final rule allowing Medicare Advantage and Part D health plans to...

FOR IMMEDIATE RELEASE April 26, 2024 WASHINGTON, D.C. – We Work For Health Executive Director Dan Leonard issued the following statement...

Today, President Biden highlighted the administration’s current and future efforts to lower healthcare costs. The good news is recent...

We Work For Health recently convened a conversation to explore the impact policy decisions have on the biopharmaceutical industry and...

We Work For Health recently released new employment, vendor and supplier expenditure data that showcases the vital contributions of these...

During his State of the Union address Thursday night, President Biden called for Congress to expand the Inflation Reduction Act to...

On Feb. 29, the House Energy and Commerce Subcommittee on Health held a hearing to review a number of bills that impact those living with...

The FDA approved 55 new drugs in 2023 — up substantially from 2022's 37 approvals, and barely behind the all-time record of 59 set in...

Feb. 01, 2024 FOR IMMEDIATE RELEASE Washington, DC (Feb. 01, 2024) – We Work For Health has issued the following statement from Executive...

The Biden administration may soon double down on one of its gravest mistakes. In 2022, it supported a petition before the World Trade...

Today, patients in the United States have greater access to the latest lifesaving and life-altering medical treatments than anywhere...

Forty-three years ago, a young U.S. Sen. Joe Biden voted for a transformative policy reform that subsequently catalyzed upwards of $2...

The idea that the government could forcibly seize ownership of a groundbreaking invention you created is chilling. But that is the...

The Biden administration may soon gut the Bayh-Dole Act, one of our nation's most important and impactful laws that also supports nearly...

The inflationary spiral that drove prices up during the first years of the Biden administration has ended. That’s the good news. The bad...

Investment in U.S. biotechnology could be about to plummet, with major implications for future innovation. It all depends on the outcome...

The International Association of Fire Fighters' General President, Edward Kelly, sent the following letter to U.S. Secretary of Commerce...

The Biden administration is out to break the law. It’s proposed a framework for federal agencies to impose “march-in” rights on patented...

If Washington state were a country, it would be the 26th-largest economy in the world. Last year, our economic output reached more than...

The proposed expansion to the Inflation Reduction Act would substantially harm U.S. biopharma, triggering hundreds of thousands of job...

The FDA just approved the first drug based on CRISPR, the revolutionary gene-editing technology. The medication treats sickle cell...

Government is a terrible allocator of resources and equally bad at interfering with free markets. A great example is the ham-handed way...